27 September 2023 - An amyloid-directed monoclonal antibody, lecanemab-irmb (Leqembi), was approved by the US FDA on 6 July 2023, to ...
25 August 2022 - Officials from the EMA tout the benefits of patient registries to support regulatory decision making for ...
1 February 2022 - Experience from clinical practice with Zolgensma, a gene therapy against certain forms of spinal muscular atrophy in ...
24 January 2020 - Rapid report shows how routine practice data should be collected and processed. ...
30 November 2018 - EMA has published revised guidelines on the tests and studies needed to support marketing authorisation applications ...
15 November 2018 - The EMA is seeking feedback on the use of patient disease registries for regulatory purposes. ...
25 September 2018 - The aim of this study was to identify guidelines and assessment tools used by health technology agencies ...
22 May 2018 - A new report from the EMA lays out recommendations for improving the use of patient registries ...
12 October 2015 - The European Medicines Agency (EMA) has launched an initiative on patient registries aimed at making better use ...